David Hallas Buys 18,348 Shares of ECO Animal Health Group (LON:EAH) Stock

ECO Animal Health Group plc (LON:EAH) insider David Hallas bought 18,348 shares of the business’s stock in a transaction on Thursday, December 4th. The shares were acquired at an average cost of GBX 109 per share, with a total value of £19,999.32.

ECO Animal Health Group Stock Performance

Shares of ECO Animal Health Group stock opened at GBX 109.48 on Friday. The firm has a market cap of £73.89 million, a PE ratio of 45.05 and a beta of -0.05. The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.81. ECO Animal Health Group plc has a 52 week low of GBX 50 and a 52 week high of GBX 114. The business’s fifty day simple moving average is GBX 89.73 and its 200-day simple moving average is GBX 77.

ECO Animal Health Group (LON:EAH) last issued its quarterly earnings data on Monday, December 1st. The company reported GBX (0.54) earnings per share (EPS) for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

Wall Street Analysts Forecast Growth

Separately, Shore Capital boosted their price target on shares of ECO Animal Health Group from GBX 150 to GBX 160 and gave the company a “buy” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of GBX 160.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.